Advertisement

Topics

Susan G. Komen®-Funded Study Shows Promise of Using Circulating Tumor Cells to Determine Risk of Breast Cancer Recurrence

09:00 EST 8 Dec 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Predicting whether breast cancer will recur may one day be as simple as a blood test, thanks to pioneering research led by Joseph A. Sparano, M.D., presented today at the 40th annual San Antonio Breast Cancer Symposium (SABCS). ...

Other Sources for this Article

Susan G. Komen
Joni Avery, 972-855-4382
press@komen.org

NEXT ARTICLE

More From BioPortfolio on "Susan G. Komen®-Funded Study Shows Promise of Using Circulating Tumor Cells to Determine Risk of Breast Cancer Recurrence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...